REG - Integrated Diag Hdgs - Result of AGM

Integrated Diagnostics HoldingsAnnouncement

29/05/2024 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240529:nRSc3308Qa&default-theme=true

RNS Number : 3308Q  Integrated Diagnostics Holdings PLC  29 May 2024

Integrated Diagnostics Holdings plc

(the "Company")

 

Result of Annual General Meeting

29 May 2024

 

 

The Company announces that at the Annual General Meeting ("AGM") held today at
the offices of Actis, 2 More London Riverside, London, SE1 2JT, all
resolutions contained in the notice of the meeting, including two special
resolutions were duly passed. The special resolutions authorise the Company to
allot shares on a non-pre-emptive basis and to make market purchases of Equity
Securities in the capital of the Company. Each of the resolutions put to the
AGM was voted on by way of a poll. The results of the poll for each resolution
were as follows:

 

 

                                                                                 VOTES FOR                 %        VOTES AGAINST  %      VOTES WITHHELD  TOTAL SHARES VOTED
 1. To receive and consider the Company's Audited Financial Statements,                 441,358,887        90.74%   45,062,906     9.26%
 together with the Reports of the Directors and the Auditor for the year ended

 31 December 2023.

                                                                                                                                          0               486,421,793
 2. To re-elect Lord Anthony Tudor St John as a Director.                               459,421,276        96.92%   14,576,146     3.08%

                                                                                                                                          12,424,371      486,421,793
 3. To re-elect Dr. Hend El-Sherbini as a Director.                                     486,412,134        100.00%  4,102          0.00%

                                                                                                                                          5,557           486,421,793
 4. To elect Sherif El Zeiny as a Director.                                             475,167,144        97.69%   11,249,092     2.31%

                                                                                                                                          5,557           486,421,793
 5. To re-elect Richard Henry Phillips as a Director.                                   462,748,330        97.63%   11,249,092     2.37%  12,424,371                  486,421,793

 6. To re-elect ~Dan Johan Wilmar Olsson as a Director.                                 461,263,507        97.31%   12,733,915     2.69%  12,424,371                  486,421,793

 7. To re-elect Hussein Hassan Choucri as a Director.                                   462,748,330        97.63%   11,249,092     2.37%  12,424,371                  486,421,793

 8. To re-elect Yvonne Stillhart as a Director.                                         473,993,320        100.00%  4,102          0.00%  12,424,371                  486,421,793

 9. To re-appoint PwC LLP as Auditor to hold office from the conclusion of this                            100.00%  0              0.00%  5,557                       486,421,793
 meeting until the conclusion of the next annual general meeting at which

 accounts are laid before the Company.

                                                                                 486,416,236
 10. To authorise the Directors to determine the Auditor's remuneration.                486,421,793        100.00%  0              0.00%  0                           486,421,793

 11. Authority to issue and allot shares.                                               470,970,353        96.82%   15,451,440     3.18%  0                           486,421,793

 12. To hold shares as Treasury Shares.                                                 486,412,134        100.00%  4,102          0.00%  5,557                       486,421,793

 13. To execute ancillary documents.                                                    486,417,691        100.00%  4,102          0.00%  0                           486,421,793

 14. To authorise the Directors to dis-apply statutory pre-emption rights.              472,455,176        97.13%   13,966,617     2.87%  0                           486,421,793

 15.  Authority for the Company to make market purchases of its own shares.             486,421,793        100.00%  0              0.00%  0                           486,421,793

 

 

Further information on the resolutions and the voting report will be available
on the Company's website at https://investors.idhcorp.com/
(https://investors.idhcorp.com/) .

 

Copies of the resolutions passed as special resolutions at the AGM will
shortly be available for inspection at the National Storage Mechanism, which
is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

-Ends-

 

For further information please contact:

 

 Integrated Diagnostics Holdings plc

 Tarek Yehia                          tarek.yehia@idhcorp.com (mailto:tarek.yehia@idhcorp.com)

 Investor Relations Director

 Company Secretary                    IDHLondon@linkgroup.co.uk (mailto:IDHLondon@linkgroup.co.uk)

 Link Company Matters Limited

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSEDFLUELSELI